To evaluate the anti‐tumor effect of TZ‐dSA3‐12 under immunocompetent conditions, we utilized a mouse tumor model in which C57BL/6J mice were subcutaneously implanted with E0771 cells that stably express human HER2 (E0771‐HER2). The gene discussed is ERBB2; the disease is neoplasm.